Filing Details
- Accession Number:
- 0001562180-18-004611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-19 16:16:58
- Reporting Period:
- 2018-11-15
- Accepted Time:
- 2018-11-19 16:16:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590877 | Regenxbio Inc. | RGNX | Biological Products, (No Disgnostic Substances) (2836) | 471851754 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652827 | Vittal Vasista | C/O Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-15 | 2,170 | $58.46 | 135,113 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 1,900 | $59.06 | 133,213 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 588 | $60.40 | 132,625 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 2,042 | $62.23 | 130,583 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 700 | $63.05 | 129,883 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 100 | $64.10 | 129,783 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $57.68 to $58.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $58.81 to $59.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $59.98 to $60.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $61.81 to $62.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $62.81 to $63.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
